Ticker
ALZNCompany Name
ALZAMEND NEURO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 5.93M | 6.03 | $ 983.31K |
3/31/2025 | $ 4.18M | 6.58 | $ 634.76K |
12/31/2024 | $ 3.95M | 5.44 | $ 725.85K |
9/30/2024 | $ 4.77M | 3.8 | $ 1.25M |
6/30/2024 | $ 1.42M | 0.49 | $ 2.88M |
3/31/2024 | $ 455.24K | 0.14 | $ 3.23M |
12/31/2023 | $ 593.61K | 0.16 | $ 3.83M |
9/30/2023 | $ 781.88K | 0.21 | $ 3.67M |
6/30/2023 | $ 2.41M | 0.88 | $ 2.74M |
3/31/2023 | $ 5.84M | 2.03 | $ 2.87M |
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for ALZAMEND NEURO INC is calculated as follows: AssetsC [ $ 1.81M ] / LiabilitesC [ $ 992.31K ]
(=) Current Ratio [ 1.83 ]
Minimum
Mar 31, 2024
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |